{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:54:32Z","timestamp":1740174872776,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy is reportedly an effective treatment strategy for squamous cell carcinoma of the anus (SCCA). However, studies regarding its use in Japanese patients remain scarce.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we present the case of an 82-year-old woman with SCCA, cStage IIIB. Chemoradiotherapy was initiated after colostomy of the anorectal mass; however, para-aortic lymph node recurrence was observed 3\u00a0months after treatment completion. Five courses of DCF chemotherapy were subsequently administered, resulting in a complete response (CR). Two years and 1\u00a0month later, the aortic lymph node was enlarged again, and the patient achieved CR again after radiotherapy. Nine months later, local recurrence was detected in the anal canal, and laparoscopic perineal rectal amputation was performed. The patient remains progression-free 5\u00a0years and 10\u00a0months after the initial treatment and 1\u00a0year and 7\u00a0months after the final treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggest that complementary treatment after DCF chemotherapy may be efficacious in Japanese patients with SCCA and help achieve CR. Despite occasional local recurrences, this approach may help achieve long-term progression-free survival.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40792-024-01873-2","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T09:02:21Z","timestamp":1711357341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Squamous cell carcinoma of the anus successfully treated with multidisciplinary therapy for metachronous metastatic and local recurrences after DCF chemotherapy: a case report"],"prefix":"10.1186","volume":"10","author":[{"given":"Ryozan","family":"Naito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3543-1874","authenticated-orcid":false,"given":"Takuya","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuma","family":"Shioi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Osone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuhisa","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroomi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Sohda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Shirabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"unstructured":"Cancer statistics. Japan: Cancer Information Service, National Cancer Center (National Cancer Registry). Ministry of Health, Labour and Welfare","key":"1873_CR1"},{"key":"1873_CR2","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/cam4.4631","volume":"11","author":"K Yamada","year":"2022","unstructured":"Yamada K, Saiki Y, Komori K, Shiomi A, Ueno M, Ito M, et al. Characteristics of anal canal cancer in Japan. Cancer Med. 2022;11:2735\u201343. https:\/\/doi.org\/10.1002\/cam4.4631.","journal-title":"Cancer Med"},{"key":"1873_CR3","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM199711063371904","volume":"337","author":"M Frisch","year":"1997","unstructured":"Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337:1350\u20138. https:\/\/doi.org\/10.1056\/NEJM199711063371904.","journal-title":"N Engl J Med"},{"key":"1873_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2021.101525","volume":"24","author":"S Sasaki","year":"2021","unstructured":"Sasaki S, Metoki H, Satoh M, Murakami T, Tanoue K, Tanaka K, et al. Association of subjective health and abnormal cervical cytology in Japanese pregnant women: an adjunct study of the Japan Environment and Children\u2019s Study. Prev Med Rep. 2021;24: 101525. https:\/\/doi.org\/10.1016\/j.pmedr.2021.101525.","journal-title":"Prev Med Rep"},{"doi-asserted-by":"publisher","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Combior KC, et al. Anal carcinoma. version 2.2023, NCCN Clinical Practice Guidelines in Oncology. https:\/\/doi.org\/10.6004\/jnccn.2023.0030.","key":"1873_CR5","DOI":"10.6004\/jnccn.2023.0030"},{"unstructured":"National Cancer Institute. SEER cancer statistics factsheets: anal cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/anus.html.","key":"1873_CR6"},{"key":"1873_CR7","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","volume":"30","author":"LL Gunderson","year":"2012","unstructured":"Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB, et al. Long-term update of US GI intergroup RTOG 98\u201311 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncol. 2012;30:4344\u201351. https:\/\/doi.org\/10.1200\/JCO.2012.43.8085.","journal-title":"J Clin Oncol"},{"key":"1873_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial. Lancet Oncol. 2013;14:516\u201324. https:\/\/doi.org\/10.1016\/S1470-2045(13)70086-X.","journal-title":"Lancet Oncol"},{"key":"1873_CR9","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","volume":"30","author":"D Peiffert","year":"2012","unstructured":"Peiffert D, Tournier-Rangeard L, G\u00e9rard JP, Lemanski C, Fran\u00e7ois E, Giovannini M, et al. Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER Accord 03 trial. J Clin Oncol. 2012;30:1941\u20138. https:\/\/doi.org\/10.1200\/JCO.2011.35.4837.","journal-title":"J Clin Oncol"},{"key":"1873_CR10","first-page":"861","volume":"86","author":"C Faivre","year":"1999","unstructured":"Faivre C, Rougier P, Ducreux M, Mitry E, Lusinchi A, Lasser P, et al. Carcinome \u00e9pidermo\u00efde m\u00e9tastatique de l\u2019anus: \u00e9tude r\u00e9trospective de l\u2019efficacit\u00e9 de l\u2019association de 5-fluoro-uracile en perfusion continue et de cisplatin. Bull Cancer. 1999;86:861\u20135.","journal-title":"Bull Cancer"},{"key":"1873_CR11","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S1470-2045(18)30321-8","volume":"19","author":"S Kim","year":"2018","unstructured":"Kim S, Fran\u00e7ois E, Andr\u00e9 T, Samalin E, Jary M, El Hajbi F, et al. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2018;19:1094\u2013106. https:\/\/doi.org\/10.1016\/S1470-2045(18)30321-8.","journal-title":"Lancet Oncol"},{"key":"1873_CR12","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1200\/JCO.19.03266","volume":"38","author":"S Rao","year":"2020","unstructured":"Rao S, Sclafani F, Eng C, Adams RA, Guren MG, Sebag-Montefiore D, et al. International rare cancers initiative multicenter randomized Phase II trial of cisplatin and fluorouracil versus carboplatin and paclitaxel in advanced anal cancer: InterAAct. J Clin Oncol. 2020;38:2510\u20138. https:\/\/doi.org\/10.1200\/JCO.19.03266.","journal-title":"J Clin Oncol"},{"key":"1873_CR13","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.3748\/wjg.v21.i8.2294","volume":"21","author":"M Ghosn","year":"2015","unstructured":"Ghosn M, Kourie HR, Abdayem P, Antoun J, Nasr D. Anal cancer treatment: current status and future perspectives. World J Gastroenterol. 2015;21:2294\u2013302. https:\/\/doi.org\/10.3748\/wjg.v21.i8.2294.","journal-title":"World J Gastroenterol"},{"key":"1873_CR14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63:1129\u201336. https:\/\/doi.org\/10.1016\/0092-8674(90)90409-8.","journal-title":"Cell"},{"key":"1873_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nm0196-72","volume":"2","author":"AF Wahl","year":"1996","unstructured":"Wahl AF, Donaldson KL, Fairchild C, Lee FY, Foster SA, Demers GW, et al. Loss of normal p53 function confers sensitization to Taxol by increasing G2\/M arrest and apoptosis. Nat Med. 1996;2:72\u20139. https:\/\/doi.org\/10.1038\/nm0196-72.","journal-title":"Nat Med"},{"key":"1873_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40164-023-00413-2","volume":"12","author":"S Kim","year":"2023","unstructured":"Kim S, Vendrely V, Saint A, Andr\u00e9 T, Vaflard P, Samalin E, et al. DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study. Exp Hematol Oncol. 2023;12:63. https:\/\/doi.org\/10.1186\/s40164-023-00413-2.","journal-title":"Exp Hematol Oncol"},{"key":"1873_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejca.2021.11.019","volume":"162","author":"M Stouvenot","year":"2022","unstructured":"Stouvenot M, Meurisse A, Saint A, Buecher B, Andr\u00e9 T, Samalin E, et al. Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies. Eur J Cancer. 2022;162:138\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2021.11.019.","journal-title":"Eur J Cancer"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-024-01873-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-024-01873-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-024-01873-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T09:02:24Z","timestamp":1711357344000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-024-01873-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1186\/s40792-024-01873-2","relation":{},"ISSN":["2198-7793"],"issn-type":[{"type":"electronic","value":"2198-7793"}],"subject":[],"published":{"date-parts":[[2024,3,25]]},"assertion":[{"value":"12 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient\u2019s privacy was protected, and this paper does not include any patient-identifying information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}